Improved in vivo gene transfer into tumor tissue by stabilization of pseudodendritic oligoethylenimine-based polyplexes

Journal of Gene Medicine

Volumn 12, Issue 2, 2010, Pages 180-193

  Russ, Verena ^a   Fr̈ohlich, Thomas ^a   Li, Yunqiu ^a   Halama, Anna ^a   Ogris, Manfred ^a   Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer; Degradable polymer; Gene transfer; Polyplex; Targeting; Transferrin

Indexed keywords

3,3' DITHIOBIS(SUCCINIMIDYL PROPIONATE); ACRYLIC ACID DERIVATIVE; AZIRIDINE DERIVATIVE; DISUCCINIMIDYLSUBERATE; ENHANCED GREEN FLUORESCENT PROTEIN; ESTER DERIVATIVE; HD O POLYPLEX; HEXANEDIOL DIACRYLATE DIESTER DERIVATIVE; LIGAND; LUCIFERASE; OLIGOETHYLENIMINE; PERIODATE; PLASMID DNA; POLYMER; SCHIFF BASE; SUCCINIMIDE DERIVATIVE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN K 562; CONTROLLED STUDY; CROSS LINKING; DISULFIDE BOND; DRUG TARGETING; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; TUMOR;

ACRYLATES; ANIMALS; CELL LINE, TUMOR; COLLOIDS; CROSS-LINKING REAGENTS; DENDRIMERS; DNA; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HUMANS; INJECTIONS, INTRAVENOUS; LUCIFERASES; MICE; NEOPLASMS; POLYETHYLENEIMINE; RECEPTORS, TRANSFERRIN; SURFACE PROPERTIES; TIME FACTORS; TRANSFERRIN;

MUS;

EID: 76049111642     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1430     Document Type: Article

References (31)

1. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007 - an update. J Gene Med 2007; 9: 833-842.
2. Ogris M, Brunner S, Schuller S, et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
3. Oupicky D, Ogris M, Howard KA, et al. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther 2002; 5: 463-472.
4. Barron LG, Uyechi LS, Szoka FC Jr. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther 1999; 6: 1179-1183.
5. Dash PR, Read ML, Barrett LB, et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643-650.
6. Burke RS, Pun SH. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem 2008; 19: 693-704.
7. Oupicky D, Parker AL, Seymour LW. Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors. J Am Chem Soc 2002; 124: 8-9.
8. Neu M , Sitterberg J, Bakowsky U, et al. Stabilized nanocarriers for plasmids based upon cross-linked poly(ethylene imine). Biomacromolecules 2006; 7: 3428-3438.
9. Neu M, Germershaus O, Mao S, et al. Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: in vitro characterization and in vivo studies in mice. J Control Release 2007; 118: 370-380.
10. Dash PR, Read ML, Fisher KD, et al. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J Biol Chem 2000; 275: 3793-3802.
11. Neu M, Germershaus O, Behe M, et al. Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo. J Control Release 2007; 124: 69-80.
12. Oupicky D, Carlisle RC, Seymour LW. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther 2001; 8: 713-724.
13. Miyata K, Kakizawa Y, Nishiyama N, et al. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc 2004; 126: 2355-2361.
14. Carlisle RC, Etrych T, Briggs SS, et al. Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J Gene Med 2004; 6: 337-344.
15. Russ V, Elfberg H, Thoma C, et al. Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer. Gene Ther 2008; 15: 18-29.
16. Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002; 22: 225-250.
17. Xu L, Pirollo KF, Tang WH, et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999; 10: 2941-2952.
18. Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/ DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28-40.
19. Kircheis R, Blessing T, Brunner S, et al. Tumor targeting with surface-shielded ligand - polycation DNA complexes. J Control Release 2001; 72: 165-170.
20. Plank C, Zatloukal K, Cotten M, et al. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug Chem 1992; 3: 533-539.
21. Kircheis R, Kichler A, Wallner G, et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997; 4: 409-418.
22. Wagner E, Cotten M, Mechtler K, et al. DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconjug Chem 1991; 2: 226-231.
23. Shir A, Ogris M,Wagner E, et al. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med 2006; 3: E6.
24. Hu-Lieskovan S, Heidel JD, Bartlett DW, et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res 2005; 65: 8984-8992.
25. da Cruz MT, Cardoso AL, de Almeida LP, et al. Tf-lipoplexmediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury. Gene Ther 2005; 12: 1242-1252.
26. Wolschek MF, Thallinger C, Kursa M, et al. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 2002; 36: 1106-1114.
27. Ogris M, Walker G, Blessing T, et al. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/ DNA complexes. J Control Release 2003; 91: 173-181.
28. Kunath K, Merdan T, Hegener O, et al. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 2003; 5: 588-599.
29. Kursa M, Walker GF, Roessler V, et al. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem 2003; 14: 222-231.
30. Walker GF, Fella C, Pelisek J, et al. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther 2005; 11: 418-425.
31. Kim YH, Park JH, Lee M, et al. Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release 2005; 103: 209-219.